Article Sidebar

PDF (Tiếng Việt)
Published: 2024-10-30
Abstract Views: 43
Views PDF (Tiếng Việt): 12
DOI: https://doi.org/10.52163/yhc.v65i6.1704
Issue
Vol. 65 No. 6
Section
Articles
How to Cite
Thủy, H. T. T., & Tùng, N. Q. (2024). 48. RARE CASE: BONE MARROW INVASIVE T-CELL NON-HODGKIN LYMPHOMA IN A PATIENT WITH HEMOPHILIA A. Vietnam Journal of Community Medicine, 65(6). https://doi.org/10.52163/yhc.v65i6.1704

48. RARE CASE: BONE MARROW INVASIVE T-CELL NON-HODGKIN LYMPHOMA IN A PATIENT WITH HEMOPHILIA A

Hoang Thi Thu Thuy1, Nguyen Quang Tung1
1 Hanoi Medical University

Main Article Content

Abstract

Hemophilia A is a hereditary blood clotting disorder with a prevalence of 1/6000 in males. According to the GLOBOCAN database of the International Agency for Research on Cancer of the World Health Organization, among 36 different types of cancer, nonHodgkin lymphoma ranked 8th in males and 10th in females. However, it is very rare for a patient to have both diseases simultaneously. We want to report a case of T-cell non-Hodgkin lymphoma with bone marrow invasion in a patient with severe Hemophilia A. The patient was an 18-year-old male, diagnosed with Hemophilia A at the age of 4, and was regularly treated with recombinant factor VIII. During their most frequent symptoms, the patient had continuous high fever, with axillary lymphadenopathy. The chest wall ulcer gradually spread after the patient had their axillary lymphadenopathy removed, and popular lesions started appearing on their skin. Hemostasis of the ulcerated lesions was difficult despite the patient receiving factor VIII replacement until stable. Biopsy results with specific immune markers for the ulcerated lesions concluded T-cell non-Hodgkin lymphoma with bone biopsy showed bone marrow invasion. The patient was treated with CHOP chemotherapy but went into septic shock during the leukopenia phase and died.

Article Details

Keywords

Hemophilia A, non-Hodgkin lymphoma, bone marrow invasion

References

[1] Orphanet: Hemophilia A. , accessed: 09/23/2024.
[2] HS, JF, RlS et al, Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, CA Cancer J Clin, 2021, 71(3).
[3] Thandra K.C, Barsouk A, Saginala K et al, Epidemiology of Non-Hodgkin’s Lymphoma, Med Sci, 2021, 9(1), 5.
[4] Huang Y.C, Tsan Y.T, Chan W.C et al, Incidence and survival of cancers among 1,054 hemophilia patients: A nationwide and 14-year cohort study, Am J Hematol, 2015, 90(4), E55-59.
[5] Lövdahl S, Henriksson K.M, Baghaei F et al, Malignancies in Swedish persons with haemophilia: a longitudinal registry study, Blood Coagul Fibrinolysis Int J Haemost Thromb, 2016, 27(6), 631-636.
[6] Ozdemir N, Yurt A, Turkan E et al, Non-Hodgkin’s lymphoma in a hemophilic patient with a traumatic hematoma, Turk J Hematol, 2011,28(3), 237-238.
[7] Connor P, Cheung B, Rangarajan, Malignant sarcoma masquerading as a pseudotumour in a patient with mild haemophilia, Br J Haematol, 2003, 123, 191.
[8] Zülfikar B, Two patients with haemophilia and acute leukaemia, Haemoph Off J World Fed Hemoph, 2002, 8(5), 698-702.
[9] Plug I, Van der bom J.G, Peters M et al, Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study1, J Thromb Haemost, 2006, 4(3), 510-516.
[10] Conlan M.G, Bast M, Armitage J.O et al, Bone marrow involvement by non-Hodgkin’s lymphoma: the clinical significance of morphologic
discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group, J Clin Oncol Off J Am Soc Clin Oncol, 1990, 8(7), 1163-1172.